...
首页> 外文期刊>Therapeutic Drug Monitoring >Oral fluid nicotine markers to assess smoking status and recency of use.
【24h】

Oral fluid nicotine markers to assess smoking status and recency of use.

机译:口服液体尼古丁标志物,以评估吸烟状况和使用的新近度。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Oral fluid collection is noninvasive and easily observed making it an attractive matrix for objectively determining smoking status. Despite large intersubject variability, cotinine oral fluid concentrations correlate with cigarettes smoked per day (CPD). Few studies, however, assessed nicotine markers in oral fluid other than cotinine; other markers might improve smoking status assessment and/or time of last cigarette. MATERIALS AND METHODS: Smoking histories and oral fluid specimens were collected from nontreatment-seeking light (1-10 CPD) and heavy smokers (greater than 10 CPD) and from environmentally exposed and nonexposed nonsmokers who provided written informed consent for this Institutional Review Board-approved study. Nicotine, cotinine, hydroxycotinine (OH-cotinine), and norcotinine oral fluid concentrations were quantified by liquid chromatography tandem mass spectrometry. RESULTS: Comparison of 1, 3, and 10 ng/mL oral fluid liquid chromatography tandem mass spectrometry cutoffs demonstrated that 10-ng/mL cutoffs performed optimally for cotinine, OH-cotinine, nicotine, and norcotinine identifying 98%, 97%, 88%, and 15% of self-reported smokers; 1% nonsmokers had greater than 10 ng/mL cotinine. No self-reported nonsmoker had greater than 10 ng/mL OH-cotinine, nicotine, or norcotinine. Norcotinine was only identified in smokers' oral fluid. Oral fluid nicotine, cotinine, and nicotine/cotinine ratios were correlated with time of last smoking (r = -0.53, -0.23, and -0.51; P < 0.05) and CPD (r = 0.35, 0.26, and 0.33; P < 0.01), respectively. DISCUSSION AND CONCLUSION: OH-cotinine performed slightly better than cotinine for distinguishing smokers from nonsmokers and should be considered as an additional oral fluid smoking indicator. Further research is required to determine if oral fluid norcotinine is a marker for distinguishing light and heavy smokers. Moderate correlations suggest nicotine, cotinine, and nicotine/cotinine ratios may be useful for determining smoking recency in "spot samples" collected during nicotine cessation treatment.
机译:简介:口服液收集是无创的,易于观察,使其成为客观确定吸烟状况的有吸引力的基质。尽管受试者之间存在较大差异,但可替宁口腔液浓度与每天吸烟量(CPD)相关。但是,很少有研究评估可替宁以外的口腔液中尼古丁标志物的水平。其他标记可能会改善吸烟状况评估和/或最后一支香烟的时间。材料和方法:吸烟史和口腔液体标本是从未寻求治疗的轻度(1-10 CPD)和重度吸烟者(大于10 CPD)以及环境暴露和未暴露的非吸烟者收集的,这些人为此机构审查委员会提供了书面知情同意书,批准的研究。尼古丁,可替宁,羟基可卡因(OH-可卡因)和去甲烟碱口腔液浓度通过液相色谱串联质谱法定量。结果:比较1、3和10 ng / mL口服液液相色谱串联质谱法的临界值,结果表明10 ng / mL的临界值对可替宁,OH-可卡因,尼古丁和降烟碱的最佳分离性能为98%,97%,88 %,以及15%的自我报告的吸烟者; 1%的不吸烟者可替宁含量大于10 ng / mL。自我报告的不吸烟者中没有超过10 ng / mL的OH-烟碱,烟碱或降烟碱。仅在吸烟者的口腔液中鉴定出了Norcotinine。口服液尼古丁,可替宁和尼古丁/可卡因的比例与上次吸烟时间(r = -0.53,-0.23和-0.51; P <0.05)和CPD(r = 0.35、0.26和0.33; P <0.01 ), 分别。讨论与结论:OH-烟碱在区分吸烟者与非吸烟者方面的表现比可替宁稍好,应被视为一种额外的口服液体吸烟指标。需要进一步研究以确定口服液体降烟碱是否是区分轻度和重度吸烟者的标志。中等程度的相关性表明,尼古丁,可替宁和尼古丁/可卡因比可用于确定在尼古丁戒断治疗期间收集的“现场样本”中的吸烟率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号